339 related articles for article (PubMed ID: 26472175)
1. H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps.
Xie H; Wan XF; Ye Z; Plant EP; Zhao Y; Xu Y; Li X; Finch C; Zhao N; Kawano T; Zoueva O; Chiang MJ; Jing X; Lin Z; Zhang A; Zhu Y
Sci Rep; 2015 Oct; 5():15279. PubMed ID: 26472175
[TBL] [Abstract][Full Text] [Related]
2. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
3. Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.
Kosikova M; Li L; Radvak P; Ye Z; Wan XF; Xie H
Clin Infect Dis; 2018 Oct; 67(10):1523-1532. PubMed ID: 29672713
[TBL] [Abstract][Full Text] [Related]
4. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
de Jong JC; Beyer WE; Palache AM; Rimmelzwaan GF; Osterhaus AD
J Med Virol; 2000 May; 61(1):94-9. PubMed ID: 10745239
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.
Xie H; Li L; Ye Z; Li X; Plant EP; Zoueva O; Zhao Y; Jing X; Lin Z; Kawano T; Chiang MJ; Finch CL; Kosikova M; Zhang A; Zhu Y; Wan XF
Clin Infect Dis; 2017 Jul; 65(2):259-267. PubMed ID: 28369230
[TBL] [Abstract][Full Text] [Related]
7. Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.
Cobey S; Gouma S; Parkhouse K; Chambers BS; Ertl HC; Schmader KE; Halpin RA; Lin X; Stockwell TB; Das SR; Landon E; Tesic V; Youngster I; Pinsky BA; Wentworth DE; Hensley SE; Grad YH
Clin Infect Dis; 2018 Jul; 67(3):327-333. PubMed ID: 29471464
[TBL] [Abstract][Full Text] [Related]
8. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
9. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
[TBL] [Abstract][Full Text] [Related]
10. An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.
Florek KR; Campos LM; Braun KM; McLean HQ; King JP; Flannery B; Belongia EA; Friedrich TC
Vaccine; 2018 Jan; 36(5):758-764. PubMed ID: 29249543
[TBL] [Abstract][Full Text] [Related]
11. [Antigenic relationship between influenza A (H3N2) strains circulating in Argentina and vaccine strains].
Savy VL; Baumeister EG; Pontoriero AV
Medicina (B Aires); 1999; 59(3):225-30. PubMed ID: 10451559
[TBL] [Abstract][Full Text] [Related]
12. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.
Jorquera PA; Mishin VP; Chesnokov A; Nguyen HT; Mann B; Garten R; Barnes J; Hodges E; De La Cruz J; Xu X; Katz J; Wentworth DE; Gubareva LV
Sci Rep; 2019 Feb; 9(1):2676. PubMed ID: 30804469
[TBL] [Abstract][Full Text] [Related]
13. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
Ansaldi F; Canepa P; Ceravolo A; Valle L; de Florentiis D; Oomen R; Vogel FR; Denis M; Samson SI; Icardi G
Vaccine; 2012 Apr; 30(18):2908-13. PubMed ID: 22342501
[TBL] [Abstract][Full Text] [Related]
14. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
[TBL] [Abstract][Full Text] [Related]
15. Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay.
Li ZN; Liu F; Gross FL; Kim L; Ferdinands J; Carney P; Chang J; Stevens J; Tumpey T; Levine MZ
mBio; 2021 Feb; 12(1):. PubMed ID: 33531397
[TBL] [Abstract][Full Text] [Related]
16. Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.
Liu F; Veguilla V; Gross FL; Gillis E; Rowe T; Xu X; Tumpey TM; Katz JM; Levine MZ; Lu X
J Infect Dis; 2017 Sep; 216(suppl_4):S539-S547. PubMed ID: 28934461
[TBL] [Abstract][Full Text] [Related]
17. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine.
Gouma S; Weirick M; Hensley SE
Nat Commun; 2020 May; 11(1):2445. PubMed ID: 32415074
[TBL] [Abstract][Full Text] [Related]
18. Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection.
Fonville JM; Fraaij PL; de Mutsert G; Wilks SH; van Beek R; Fouchier RA; Rimmelzwaan GF
J Infect Dis; 2016 Jan; 213(1):31-8. PubMed ID: 26142433
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains.
Velazco JG; Couch RB; Six HR; Glezen WP
Bull World Health Organ; 1983; 61(2):345-52. PubMed ID: 6190585
[TBL] [Abstract][Full Text] [Related]
20. Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.
Hiroi S; Morikawa S; Nakata K; Maeda A; Kanno T; Irie S; Ohfuji S; Hirota Y; Kase T
Hum Vaccin Immunother; 2015; 11(2):386-90. PubMed ID: 25692378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
